Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. IGC Pharma Inc. (IGC) Message Board

420 with CNW – Delaware Senate Passes Cannabis L

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 436
(Total Views: 137)
Posted On: 04/05/2023 5:43:49 PM
Avatar
Posted By: NetworkNewsWire
420 with CNW – Delaware Senate Passes Cannabis Legalization Bills, Sends to Governor

Last Tuesday, the Senate in Delaware gave its nod of approval to a pair of proposals earlier voted through by the House that seek to legalize possession of cannabis and establish market regulations for the recreational consumption of cannabis. These bills will now be forwarded to the state’s governor.

The regulation proposal sailed through on a 15 to 5 vote tally, while the simple legalization proposal garnered a 16 to 4 tally in the chamber. Representative Ed Osienski sponsored both bills, which snaked their way through several legislative panels before getting a floor vote.

The sponsor made use of a similar, stratified approach for the legislation during the prior session, which resulted in the fundamental legalization draft being approved while the regulation version was narrowly defeated.

According to HB 1 as well as HB 2, the state laws would change to allow individuals over the age of 21 to have, share, use or buy as much as one ounce of marijuana. The measure stipulates that “independent person sharing” doesn’t entail distributing cannabis simultaneously with another reciprocating exchange involving the respective persons, such as exchanging a noncannabis item, to prevent abuse of the “gift-giving” provision. Marijuana cultivation as well as public use would remain illegal. Civil fines not exceeding $100 may be levied on under-aged individuals who engage in the banned behavior if it is their first violation. However, the police is at liberty to exercise restraint and impose a citation in lieu of a fine.

The measure offers a foundational framework for putting in place a controlled cannabis business system for recreational marijuana in the jurisdiction. Under the creation of the newly formed Office of the Commissioner for Marijuana Control, the Tobacco and Alcohol Enforcement Department (DATE) will be charged with overseeing the regulation of the market.

A maximum of 30 commercial cannabis permits may be issued by regulators after just 16 months of the market launching.

The scoring procedure before license issuance will give priority to candidates who demonstrate a capacity to offer a decent salary, health insurance, paid time off for illness and an emphasis on hiring a diverse pool of candidates.

A Fund for Justice Reinvestment that promotes transitional justice, job placement, technical support for the financially disadvantaged as well as similar initiatives would receive 7% of cannabis business fees.

Before this decision on Bill 2, members opposed two amendments proposed by the GOP. One intended to alter the Cannabis Regulation Commission’s organizational structure while also enabling those facing penalties, cancellation of licenses or license termination to request regulators to furnish them with the pertinent records backing such actions. This alternative bill could have removed any language referring to the necessity of marijuana companies to signing labor/employee peace agreements.

Marijuana legalization is sweeping across the country, and its growing popularity is aided by the R&D work being undertaken by enterprises such as India Globalization Capital Inc. (NYSE American: IGC), which hope to commercialize a number of medicinal formulations from different cannabinoids, such as THC.

NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer




(0)
(0)




IGC Pharma Inc. (IGC) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us